TP53 and cancer: Current therapeutic approaches under development for the treatment of such cancers involve inhibition of p53 degradation for cancers expressing WT p53 with or without lower protein expression and restoration of WT p53 function in cancers with mutated or truncated p53 expression (18, 54).